{"id":1161,"date":"2016-12-06T20:04:35","date_gmt":"2016-12-06T20:04:35","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=1161"},"modified":"2016-12-06T20:04:35","modified_gmt":"2016-12-06T20:04:35","slug":"enyo-pharma-recoit-un-financement-de-2-5-me-dans-le-cadre-du-programme-europeen-horizon-2020-sme-instrument-phase-2-pour-son-projet-mimesis","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-recoit-un-financement-de-2-5-me-dans-le-cadre-du-programme-europeen-horizon-2020-sme-instrument-phase-2-pour-son-projet-mimesis\/","title":{"rendered":"ENYO Pharma re\u00e7oit un financement de 2.5 ME dans le cadre du programme europ\u00e9en  Horizon 2020 \/ SME Instrument Phase 2,  pour son projet MIMESIS"},"content":{"rendered":"<p>Lyon, le 5 d\u00e9cembre 2016 \u2013 ENYO Pharma, soci\u00e9t\u00e9 biopharmaceutique centr\u00e9e actuellement sur le traitement des infections virales, annonce aujourd&#8217;hui avoir re\u00e7u une subvention de 2.5 M\u20ac suite \u00e0 sa candidature au tr\u00e8s s\u00e9lectif programme europ\u00e9en SME Instrument Phase 2 (taux de r\u00e9ussite moyen de 6%).<\/p>\n <a href=\"http:\/\/www.enyopharma.com\/wp-content\/uploads\/2016\/12\/PR-FR-ENYO-December-5-2016-Final.pdf\" target=\"_blank\" rel=\"\" target=\"_blank\" class=\"tano-file\"><span class=\"tano_download_icon\"><\/span><span class=\"tano_file_title\">T\u00e9l\u00e9charger le communiqu\u00e9 complet (PDF)<\/span><\/a> \n","protected":false},"excerpt":{"rendered":"<p>Lyon, le 5 d\u00e9cembre 2016 \u2013 ENYO Pharma, soci\u00e9t\u00e9 biopharmaceutique centr\u00e9e actuellement sur le traitement des infections virales, annonce aujourd&#8217;hui avoir re\u00e7u une subvention de 2.5 M\u20ac suite \u00e0 sa candidature au tr\u00e8s s\u00e9lectif programme europ\u00e9en SME Instrument Phase 2 (taux de r\u00e9ussite moyen de 6%).<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/enyo-pharma-recoit-un-financement-de-2-5-me-dans-le-cadre-du-programme-europeen-horizon-2020-sme-instrument-phase-2-pour-son-projet-mimesis\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-1161","post","type-post","status-publish","format-standard","hentry","category-press-releases-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/press-releases-fr\/\" rel=\"category tag\">Press releases<\/a>","rttpg_excerpt":"Lyon, le 5 d\u00e9cembre 2016 \u2013 ENYO Pharma, soci\u00e9t\u00e9 biopharmaceutique centr\u00e9e actuellement sur le traitement des infections virales, annonce aujourd&#8217;hui avoir re\u00e7u une subvention de 2.5 M\u20ac suite \u00e0 sa candidature au tr\u00e8s s\u00e9lectif programme europ\u00e9en SME Instrument Phase 2 (taux de r\u00e9ussite moyen de 6%).Lire la suite&nbsp;&raquo;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=1161"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1161\/revisions"}],"predecessor-version":[{"id":1162,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/1161\/revisions\/1162"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=1161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=1161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=1161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}